Agency Information Collection Activities; Proposed Collection; Comment Request; Small Business Innovation Research Program-Phase II, 46586-46587 [2015-19237]
Download as PDF
<![CDATA[
46586
Federal Register / Vol. 80, No. 150 / Wednesday, August 5, 2015 / Notices
issues are important to clinical and
public health, we expect good
participation by most states. This
mechanism will assure the best
response rate of all the options we
considered.
The CDC LRN Coordinator will email
a letter to the Laboratory Director of the
LRN Reference Laboratories, (i.e., 50
State Public Health Laboratories, the
New York City Public Health Laboratory
and the Los Angeles County Public
Health Laboratory). These 52 LRN
Reference Laboratory Directors will be
asked to then email the sentinel
laboratories, which include hospital and
independent laboratories, in their states,
and provide a hyperlink to access the
survey tool on-line. SurveyMonkey®
will host the online survey and be used
as the information collection instrument
and responses will be collected and
maintained by ASM.
We anticipate that approximately
4,200 sentinel laboratories will be
contacted and asked to complete the
survey on-line. ASM anticipates
achieving an 80% response rate with
their information collections, or 3,360
out of approximately 4,200 aggregate
responses for each of the five different
surveys.
In addition, the ASM will also recruit,
by emailing a letter containing the
SurveyMonkey® hyperlinks for the five
surveys to each of their ClinMicroNet
and DivCNet listervs inviting ∼828 and
∼1470 subscribers (comprised of
laboratory directors as well as medical
technologists in a 99%:1% and
60%:40%), respectively, to take each of
the five SurveyMonkey® surveys.
Moreover, the ASM will email the same
letter containing the SurveyMonkey®
hyperlinks for the 5 surveys to ∼1453
ASM Clinical Microbiology Issues
Update newsletter subscribers, which
include microbiology supervisors,
laboratory directors, laboratory
managers, and medical technologists in
a 25 percent:25 percent: 25 percent: 25
percent ratio, to invite them to
participate.
For burden calculations, respondents
will include microbiology supervisors,
laboratory directors, laboratory
managers, and medical technologists.
According to ASM, the burden hours
per respondent who will be invited to
participate in each of the BCC baseline
and post-dissemination surveys will not
exceed 35 minutes and each of the BSI,
UT and CDI baseline surveys will be 20
minutes. This time frame was specified
based on ASM’s previous experiences
conducting laboratory surveys. Each
survey was pilot tested with 9 or fewer
respondents before dissemination.
The total estimated annualized
burden hours for this collection is
17,225. There are no costs to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Microbiology Supervisors ................................
BCC-baseline .................................................
BCC-post ........................................................
BSI-baseline ...................................................
UT-baseline ....................................................
CDI-baseline ...................................................
BCC-baseline .................................................
BCC-post ........................................................
BSI-baseline ...................................................
UT-baseline ....................................................
CDI-baseline ...................................................
BCC-baseline .................................................
BCC-post ........................................................
BSI-baseline ...................................................
UT-baseline ....................................................
CDI-baseline ...................................................
BCC-baseline .................................................
BCC-post ........................................................
BSI-baseline ...................................................
UT-baseline ....................................................
CDI-baseline ...................................................
Laboratory Directors .......................................
Laboratory Managers ......................................
Medical Technologists ....................................
LeRoy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
[FR Doc. 2015–19114 Filed 8–4–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Small Business
Innovation Research Program—Phase
II
National Institute on Disability,
Independent Living and Rehabilitation,
Administration for Community Living
(ACL), HHS.
AGENCY:
ACTION:
VerDate Sep<11>2014
16:54 Aug 04, 2015
Jkt 235001
PO 00000
Notice.
Frm 00049
Fmt 4703
Sfmt 4703
2,463
2,463
2,463
2,463
2,463
3,115
3,115
3,115
3,115
3,115
1,413
1,413
1,413
1,413
1,413
960
960
960
960
960
Number of
responses
per
respondent
Average
burden per
response
(in hrs.)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
35/60
35/60
20/60
20/60
20/60
35/60
20/60
20/60
20/60
20/60
35/60
35/60
20/60
20/60
20/60
35/60
20/60
20/60
20/60
20/60
The Administration for
Community Living (ACL), National
Institute on Disability, Independent
Living, and Rehabilitation Research
(NIDLRR) is announcing an opportunity
for public comment on the proposed
collection of certain information. Under
the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required
to publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
SUMMARY:
E:\FR\FM\05AUN1.SGM
05AUN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 150 / Wednesday, August 5, 2015 / Notices
the information collection requirements
relating to the Small Business
Innovation Research Program (SBIR)—
Phase II.
DATES: Submit written or electronic
comments on the collection of
information by October 5, 2015.
ADDRESSES: Submit electronic
comments on the collection of
information to: Brian.Bard@acl.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Brian Bard at 202–254–7345 or
Brian.Bard@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, ACL/NIDILRR is
publishing notice of the proposed
collection of information set forth in
this document. With respect to the
following collection of information,
ACL/NIDILRR invites comments on: (1)
Whether the proposed collection of
information is necessary for the proper
performance of ACL/NIDILRR’s
functions, including whether the
information will have practical utility;
(2) the accuracy of ACL/NIDILRR’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques
when appropriate, and other forms of
information technology. ACL/NIDILRR
proposes to use this set of data
collection tools to be used as a grant
application package for the information
used to apply for new grants under the
SBIR program (Phase II).
Public Law 106–554, the ‘‘Small
Business Reauthorization Act of 2000,
H.R. 5567’’ (the ‘‘Act’’) was enacted on
December 21, 2000. The Act requires
certain agencies, including the
VerDate Sep<11>2014
16:54 Aug 04, 2015
Jkt 235001
Department of Health and Human
Services (HHS) to establish a Small
Business Innovation Research (SBIR)
program by reserving a statutory
percentage of their extramural research
and development budgets to be awarded
to small business concerns for research
or research and development (R/R&D)
through a uniform, highly competitive,
three-phase process each fiscal year.
The Act further requires the Small
Business Administration (SBA) to issue
policy directives for the general conduct
of the SBIR programs within the Federal
Government. The purpose of this
program is to stimulate technological
Innovation in the private sector,
strengthen the role of small business in
meeting Federal research and research
and development needs, increase the
commercial application of Department
of Education (ED) supported research
results, and improve the return on
investment from Federally-funded
research for economic and social
benefits to the Nation.
Awards are made on the basis of
competitively reviewed applications.
The Department is requesting approval
of this grant application package for the
information used to apply for new
grants under the Small Business
Innovation Research (SBIR) Phase II
program. Phase I is intended to
determine, insofar as possible, the
scientific or technical merit and
feasibility of ideas. Phase II is intended
to expand on the results of and to
further pursue the development of a
Phase I project. Phase II is the principal
research and research and development
effort. It requires a more comprehensive
application, outlining the effort in detail
including the commercial potential.
Phase II applications must be Phase I
grantees with findings that appear
sufficiently promising as a result of
Phase I. Applications are evaluated
based on published criteria by panels of
experts.
ACL/NIDILRR estimates the burden of
this collection of information as 240
hours for project staff, 320 for reviewers,
and 1,080 hours for individuals. Total
burden is 1,640 hours per year.
Dated: July 31, 2015.
Kathy Greenlee,
Administrator and Assistant Secretary for
Aging.
[FR Doc. 2015–19237 Filed 8–4–15; 8:45 am]
BILLING CODE 4154–01–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
46587
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–D–1009]
Use of Nanomaterials in Food for
Animals; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of guidance for industry
#220 entitled ‘‘Use of Nanomaterials in
Food for Animals.’’ The guidance
describes FDA’s current thinking
regarding the use of nanomaterials or
the application of nanotechnology in
food for animals. It is intended to assist
industry and other stakeholders in
identifying potential issues related to
the safety or regulatory status of food for
animals containing nanomaterials or
otherwise involving the application of
nanotechnology.
SUMMARY:
Submit either electronic or
written comments on Agency guidances
at any time.
ADDRESSES: Submit written requests for
single copies of the guidance to the
Policy and Regulations Staff (HFV–6),
Center for Veterinary Medicine, Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855. Send one selfaddressed adhesive label to assist that
office in processing your requests. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance
document.
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Dragan Momcilovic, Center for
Veterinary Medicine (HFV–226), Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855, 240–453–
6856, dragan.momcilovic@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background
In the Federal Register of June 27,
2014 (79 FR 36530), FDA published the
notice of availability for a draft guidance
#220 entitled ‘‘Use of Nanomaterials in
Food for Animals’’ giving interested
persons until September 10, 2014, to
comment on the draft guidance. FDA
received several comments on the draft
guidance and those comments were
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 80, Number 150 (Wednesday, August 5, 2015)]
[Notices]
[Pages 46586-46587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19237]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Agency Information Collection Activities; Proposed Collection;
Comment Request; Small Business Innovation Research Program--Phase II
AGENCY: National Institute on Disability, Independent Living and
Rehabilitation, Administration for Community Living (ACL), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Administration for Community Living (ACL), National
Institute on Disability, Independent Living, and Rehabilitation
Research (NIDLRR) is announcing an opportunity for public comment on
the proposed collection of certain information. Under the Paperwork
Reduction Act of 1995 (the PRA), Federal agencies are required to
publish notice in the Federal Register concerning each proposed
collection of information, including each proposed extension of an
existing collection of information, and to allow 60 days for public
comment in response to the notice. This notice solicits comments on
[[Page 46587]]
the information collection requirements relating to the Small Business
Innovation Research Program (SBIR)--Phase II.
DATES: Submit written or electronic comments on the collection of
information by October 5, 2015.
ADDRESSES: Submit electronic comments on the collection of information
to: Brian.Bard@acl.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Brian Bard at 202-254-7345 or
Brian.Bard@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, ACL/NIDILRR is publishing notice of the proposed
collection of information set forth in this document. With respect to
the following collection of information, ACL/NIDILRR invites comments
on: (1) Whether the proposed collection of information is necessary for
the proper performance of ACL/NIDILRR's functions, including whether
the information will have practical utility; (2) the accuracy of ACL/
NIDILRR's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques when appropriate, and other forms of
information technology. ACL/NIDILRR proposes to use this set of data
collection tools to be used as a grant application package for the
information used to apply for new grants under the SBIR program (Phase
II).
Public Law 106-554, the ``Small Business Reauthorization Act of
2000, H.R. 5567'' (the ``Act'') was enacted on December 21, 2000. The
Act requires certain agencies, including the Department of Health and
Human Services (HHS) to establish a Small Business Innovation Research
(SBIR) program by reserving a statutory percentage of their extramural
research and development budgets to be awarded to small business
concerns for research or research and development (R/R&D) through a
uniform, highly competitive, three-phase process each fiscal year. The
Act further requires the Small Business Administration (SBA) to issue
policy directives for the general conduct of the SBIR programs within
the Federal Government. The purpose of this program is to stimulate
technological Innovation in the private sector, strengthen the role of
small business in meeting Federal research and research and development
needs, increase the commercial application of Department of Education
(ED) supported research results, and improve the return on investment
from Federally-funded research for economic and social benefits to the
Nation.
Awards are made on the basis of competitively reviewed
applications. The Department is requesting approval of this grant
application package for the information used to apply for new grants
under the Small Business Innovation Research (SBIR) Phase II program.
Phase I is intended to determine, insofar as possible, the scientific
or technical merit and feasibility of ideas. Phase II is intended to
expand on the results of and to further pursue the development of a
Phase I project. Phase II is the principal research and research and
development effort. It requires a more comprehensive application,
outlining the effort in detail including the commercial potential.
Phase II applications must be Phase I grantees with findings that
appear sufficiently promising as a result of Phase I. Applications are
evaluated based on published criteria by panels of experts.
ACL/NIDILRR estimates the burden of this collection of information
as 240 hours for project staff, 320 for reviewers, and 1,080 hours for
individuals. Total burden is 1,640 hours per year.
Dated: July 31, 2015.
Kathy Greenlee,
Administrator and Assistant Secretary for Aging.
[FR Doc. 2015-19237 Filed 8-4-15; 8:45 am]
BILLING CODE 4154-01-P
